UPDATE: PTC Therapeutics (PTCT) Initiated Neutral at UBS
Tweet
Share
E-mail
Get Alerts PTCT Hot Sheet
Price: $81.52 +3.22%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 23
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 9 | New: 23
Join SI Premium – FREE
(Updated - October 27, 2020 5:00 PM EDT)
UBS analyst Colin Bristow started PTC Therapeutics (NASDAQ: PTCT) at Neutral, PT $55.00
You May Also Be Interested In
- Benchmark Starts Boyd Gaming (BYD) at Buy
- Citizens Starts NRC Health (NRC) at Market Outperform
- Oppenheimer Assumes BridgeBio Oncology Therapeutics, In (BBOT) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
